Latest Ghost Tree Capital, LLC Stock Portfolio
$331Million | No. of Holdings #50
Ghost Tree Capital, LLC Performance
2024 Q3+6.19%
YTD+5.00%
2023-4.97%
About Ghost Tree Capital, LLC and 13F Hedge Fund Stock Holdings
On 2024-11-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Ghost Tree Capital, LLC reported an equity portfolio of $331 Millions as of 30 Sep, 2024. <br><br> The top stock holdings of Ghost Tree Capital, LLC are SRPT, , BPMC. The fund has invested 4.5% of it's portfolio in SAREPTA THERAPEUTICS INC and 4% of portfolio in NOVO-NORDISK A S. <br><br> The fund managers got completely rid off BIOHAVEN LTD, ACADIA PHARMACEUTICALS INC (ACAD) and CABALETTA BIO INC (CABA) stocks. They significantly reduced their stock positions in VIRIDIAN THERAPEUTICS INC (VRDN), SPYRE THERAPEUTICS INC (AGLE) and ENGENE HOLDINGS INC. Ghost Tree Capital, LLC opened new stock positions in NOVO-NORDISK A S, EDGEWISE THERAPEUTICS INC (EWTX) and DYNE THERAPEUTICS INC (DYN). The fund showed a lot of confidence in some stocks as they added substantially to JANUX THERAPEUTICS INC (JANX), BLUEPRINT MEDICINES CORP (BPMC) and SAREPTA THERAPEUTICS INC (SRPT).
Ghost Tree Capital, LLC Equity Portfolio Value
Last Reported on: 14 Nov, 2024
$331Million
as of Nov 14, 2024Ghost Tree Capital, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Ghost Tree Capital, LLC made a return of 6.19% in the last quarter. In trailing 12 months, it's portfolio return was 17.67%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| novo-nordisk a s | 13,097,700 |
| edgewise therapeutics inc | 5,204,550 |
| dyne therapeutics inc | 3,592,000 |
| corvus pharmaceuticals inc | 2,640,000 |
| absci corporation | 2,101,000 |
| capricor therapeutics inc | 1,901,250 |
| summit therapeutics inc | 1,861,500 |
| larimar therapeutics inc | 1,310,000 |
New stocks bought by Ghost Tree Capital, LLC
Additions
| Ticker | % Inc. |
|---|---|
| janux therapeutics inc | 280 |
| blueprint medicines corp | 250 |
| sarepta therapeutics inc | 118 |
| annexon inc | 109 |
| arvinas inc | 93.33 |
| taysha gene therapies inc | 72.00 |
| regenxbio inc | 55.88 |
| tarsus pharmaceuticals inc | 48.94 |
Additions to existing portfolio by Ghost Tree Capital, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| viridian therapeutics inc | -87.24 |
| spyre therapeutics inc | -76.02 |
| engene holdings inc | -61.72 |
| moonlake immunotherapeutics | -57.2 |
| apellis pharmaceuticals inc | -51.85 |
| soleno therapeutics inc | -50.00 |
| vaxcyte inc | -46.67 |
| ascendis pharma a/s | -39.46 |
Ghost Tree Capital, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| elevation oncology inc | -1,620,000 |
| biohaven ltd | -17,007,900 |
| pmv pharmaceuticals inc | -607,500 |
| cabaletta bio inc | -2,774,320 |
| cytomx therapeutics inc | -366,000 |
| acadia pharmaceuticals inc | -3,656,250 |
| revance therapeutics inc | -578,250 |
| sagimet biosciences inc | -769,500 |
Ghost Tree Capital, LLC got rid off the above stocks
Sector Distribution
Ghost Tree Capital, LLC has about 81.2% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 81.2 |
| Others | 18.8 |
Market Cap. Distribution
Ghost Tree Capital, LLC has about 7.4% of it's portfolio invested in the large-cap and mega-cap stocks.
- MID-CAP
- SMALL-CAP
- UNALLOCATED
- LARGE-CAP
- MICRO-CAP
| Category | % |
|---|---|
| MID-CAP | 37.2 |
| SMALL-CAP | 30.4 |
| UNALLOCATED | 18.8 |
| LARGE-CAP | 7.4 |
| MICRO-CAP | 6.2 |
Stocks belong to which Index?
About 57.7% of the stocks held by Ghost Tree Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 57.7 |
| Others | 42.3 |
Ghost Tree Capital, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Ghost Tree Capital, LLC
Ghost Tree Capital, LLC has 50 stocks in it's portfolio. About 33.6% of the portfolio is in top 10 stocks. CRBP proved to be the most loss making stock for the portfolio. PCVX was the most profitable stock for Ghost Tree Capital, LLC last quarter.
$275.79MTotal Value
67.00Positions
14 Nov, 2024Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Absci Corporation Ghost Tree Capital, LLC's holding in Absci Corporation over time | 0.64% | 550,000 | $2.10M 0.64% | Newnew position | |
 Acadia Pharmaceuticals Inc Ghost Tree Capital, LLC's holding in Acadia Pharmaceuticals Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Spyre Therapeutics Inc Ghost Tree Capital, LLC's holding in Spyre Therapeutics Inc over time | 0.53% | 60,000 | $1.76M 0.53% | 76.02%decreased 76.02 percentreduced | |
 Amylyx Pharmaceuticals Inc Ghost Tree Capital, LLC's holding in Amylyx Pharmaceuticals Inc over time | 0.32% | 325,000 | $1.05M 0.32% | Newnew position | |
 Annexon Inc Annexon IncANNX Ghost Tree Capital, LLC's holding in Annexon Inc over time | 1.16% | 650,000 | $3.85M 1.16% | 109.68%increased 109.68 percentadded | |
 An2 Therapeutics Inc Ghost Tree Capital, LLC's holding in An2 Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Apellis Pharmaceuticals Inc Ghost Tree Capital, LLC's holding in Apellis Pharmaceuticals Inc over time | 0.57% | 65,000 | $1.87M 0.57% | 51.85%decreased 51.85 percentreduced | |
 Arvinas Inc Arvinas IncARVN Ghost Tree Capital, LLC's holding in Arvinas Inc over time | 1.08% | 145,000 | $3.57M 1.08% | 93.33%increased 93.33 percentadded | |
 Arrowhead Pharmaceuticals In Ghost Tree Capital, LLC's holding in Arrowhead Pharmaceuticals In over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Axsome Therapeutics Inc Ghost Tree Capital, LLC's holding in Axsome Therapeutics Inc over time | 3.66% | 135,000 | $12.13M 3.66% | 10%decreased 10 percentreduced | |
 Bridgebio Pharma Inc Ghost Tree Capital, LLC's holding in Bridgebio Pharma Inc over time | 1.35% | 175,000 | $4.46M 1.35% | 25%increased 25 percentadded | |
 Blueprint Medicines Corp Ghost Tree Capital, LLC's holding in Blueprint Medicines Corp over time | 3.91% | 140,000 | $12.95M 3.91% | 250%increased 250 percentadded | |
 Cabaletta Bio Inc Ghost Tree Capital, LLC's holding in Cabaletta Bio Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Capricor Therapeutics Inc Ghost Tree Capital, LLC's holding in Capricor Therapeutics Inc over time | 0.57% | 125,000 | $1.90M 0.57% | Newnew position | |
 Corbus Pharmaceuticals Hldgs Ghost Tree Capital, LLC's holding in Corbus Pharmaceuticals Hldgs over time | 1% | 160,000 | $3.30M 1% | 8.57%decreased 8.57 percentreduced | |
 Crinetics Pharmaceuticals In Ghost Tree Capital, LLC's holding in Crinetics Pharmaceuticals In over time | 2.32% | 150,000 | $7.67M 2.32% | 37.5%decreased 37.5 percentreduced | |
 Corvus Pharmaceuticals Inc Ghost Tree Capital, LLC's holding in Corvus Pharmaceuticals Inc over time | 0.8% | 500,000 | $2.64M 0.8% | Newnew position | |
 Cytomx Therapeutics Inc Ghost Tree Capital, LLC's holding in Cytomx Therapeutics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Cytokinetics Inc Cytokinetics IncCYTK Ghost Tree Capital, LLC's holding in Cytokinetics Inc over time | 0% | 0.00 | $0.00 0% | 100%decreased 100 percentsold off | |
 Dyne Therapeutics Inc Ghost Tree Capital, LLC's holding in Dyne Therapeutics Inc over time | 1.08% | 100,000 | $3.59M 1.08% | Newnew position | |